90 related articles for article (PubMed ID: 21232193)
21. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
[TBL] [Abstract][Full Text] [Related]
22. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
23. [Causes of local recurrence after curative surgery for rectal cancer].
Hôhn J; Varga L; Baradnay G; Simonka Z; Géczi T; Nagy F; Molnár T; Maráz A; Kahán Z; Balogh A
Magy Onkol; 2003; 47(4):355-9. PubMed ID: 14716430
[TBL] [Abstract][Full Text] [Related]
24. Surgery for locally recurrent rectal cancer.
Boyle KM; Sagar PM; Chalmers AG; Sebag-Montefiore D; Cairns A; Eardley I
Dis Colon Rectum; 2005 May; 48(5):929-37. PubMed ID: 15785880
[TBL] [Abstract][Full Text] [Related]
25. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
26. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
27. [Evolution of surgery for cancer of the anorectal junction].
Prete F; Prete FP; Nitti P; De Luca R; Vincenti L
Chir Ital; 2007; 59(6):763-70. PubMed ID: 18360980
[TBL] [Abstract][Full Text] [Related]
28. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
29. Is palliative resection of the primary tumour, in the presence of advanced rectal cancer, a safe and useful technique for symptom control?
Al-Sanea N; Isbister WH
ANZ J Surg; 2004 Apr; 74(4):229-32. PubMed ID: 15043733
[TBL] [Abstract][Full Text] [Related]
30. Operative and functional results of total mesorectal excision with ultra-low anterior resection in the management of carcinoma of the lower one-third of the rectum.
McAnena OJ; Heald RJ; Lockhart-Mummery HE
Surg Gynecol Obstet; 1990 Jun; 170(6):517-21. PubMed ID: 1693016
[TBL] [Abstract][Full Text] [Related]
31. Preoperative chemoradiation and coloanal J pouch reconstruction for low rectal cancer.
Chaudhry V; Nittala M; Prasad ML
Am Surg; 2000 Apr; 66(4):387-93. PubMed ID: 10776877
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ
Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295
[TBL] [Abstract][Full Text] [Related]
33. Transanal local wide excision for rectal adenocarcinoma.
Chen CC; Leu SY; Liu MC; Jian JJ; Chen CM
Hepatogastroenterology; 2005; 52(62):460-3. PubMed ID: 15816457
[TBL] [Abstract][Full Text] [Related]
34. Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients.
Piso P; Dahlke MH; Mirena P; Schmidt U; Aselmann H; Schlitt HJ; Raab R; Klempnauer J
J Surg Oncol; 2004 Jun; 86(3):115-21. PubMed ID: 15170648
[TBL] [Abstract][Full Text] [Related]
35. Complications and survival after surgery for rectal cancer in patients younger than and aged 75 years or older.
Vironen JH; Sainio P; Husa AI; Kellokumpu IH
Dis Colon Rectum; 2004 Jul; 47(7):1225-31. PubMed ID: 15164247
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
[TBL] [Abstract][Full Text] [Related]
37. Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma.
Luna-Pérez P; Rodríguez-Ramírez S; Vega J; Sandoval E; Labastida S
Rev Invest Clin; 2001; 53(5):388-95. PubMed ID: 11795103
[TBL] [Abstract][Full Text] [Related]
38. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
39. [Postoperative complications of curative treatment for rectal cancer in males with sphincter-preserving total mesorectal excision].
Szynglarewicz B; Matkowski R; Sydor D; Forgacz J; Pudełko M; Grzebieniak Z
Pol Merkur Lekarski; 2007 Nov; 23(137):348-51. PubMed ID: 18361317
[TBL] [Abstract][Full Text] [Related]
40. [Laparoscopic rectal excision for cancer using total mesorectaol excision (TME). Long term outcome of a series of 179 patients].
Lechaux D; Redon Y; Trebuchet G; Lecalve JL; Campion JP; Meunier B
Ann Chir; 2005 Apr; 130(4):224-34. PubMed ID: 15847857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
